Literature DB >> 8362599

Megakaryocyte, erythroid and granulocyte-macrophage colony formation in myelodysplastic syndromes.

K Dan1, E An, M Futaki, K Inokuchi, S Gomi, T Yamada, K Ogata, Y Tanabe, I Ohki, T Shinohara.   

Abstract

Bone marrow progenitor cell assays of three cell lineages, i.e., colony-forming unit megakaryocytes (CFU-Meg), burst-forming unit erythrocytes (BFU-E) and colony-forming unit granulocyte-macrophages (CFU-GM), were performed for 21 patients with myelodysplastic syndromes (MDS). Markedly reduced or absent colony formation was found in 67% of the patients for CFU-Meg and all patients except 2 with refractory anemia (RA) for BFU-E. Abnormal CFU-GM colony formation was found in only 5 of 12 patients with RA and RA with ring sideroblasts, in contrast to all of the RA patients with excess of blasts and excess of blasts in transformation. Defective colony formation of all three cell lineages was seen in 63% of the MDS patients. The colony number of CFU-Meg correlated significantly with the numbers of both BFU-E and CFU-GM. These findings indicate that hematopoiesis in MDS patients is disturbed due to a qualitative or quantitative defect at the multipotent stem cell level.

Entities:  

Mesh:

Year:  1993        PMID: 8362599     DOI: 10.1159/000204502

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  3 in total

1.  Enhanced growth of myelodysplastic colonies in hypoxic conditions.

Authors:  James Edwin Thompson; Joseph Patrick Conlon; Xiaowei Yang; Patricia Vanessa Sanchez; Martin Carroll
Journal:  Exp Hematol       Date:  2007-01       Impact factor: 3.084

2.  Lineage-unrestricted hematologic response to granulocyte colony-stimulating factor in a patient with refractory anemia with excess blasts.

Authors:  N Yokose; K Ogata; E An; H Tamura; K Kamikubo; K Dan; T Nomura
Journal:  Ann Hematol       Date:  1995-03       Impact factor: 3.673

3.  Inhibition of apoptosis by BCL2 prevents leukemic transformation of a murine myelodysplastic syndrome.

Authors:  Christopher I Slape; Jesslyn Saw; Jeremy B M Jowett; Peter D Aplan; Andreas Strasser; Stephen M Jane; David J Curtis
Journal:  Blood       Date:  2012-07-31       Impact factor: 22.113

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.